SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-015390
Filing Date
2019-08-12
Accepted
2019-08-12 17:54:50
Documents
1
Period of Report
2019-08-08

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5920
  Complete submission text file 0001213900-19-015390.txt   7422
Mailing Address 401 TERRY AVENUE NORTH SEATTLE WA 98109
Business Address 401 TERRY AVENUE NORTH SEATTLE WA 98109 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DRACHMAN JONATHAN G (Reporting) CIK: 0001588467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 191017790